AAAAAA

   
Results: 1-8 |
Results: 8
DIFFERENT EFFECTS OF CALCIUM-ANTAGONISTS ON FLUID FILTRATION OF LARGEARTERIES AND ALBUMIN PERMEABILITY IN SPONTANEOUSLY HYPERTENSIVE RATS
Authors: LACOLLEY P POITEVIN P KOEN R LEVY BI
Citation: P. Lacolley et al., DIFFERENT EFFECTS OF CALCIUM-ANTAGONISTS ON FLUID FILTRATION OF LARGEARTERIES AND ALBUMIN PERMEABILITY IN SPONTANEOUSLY HYPERTENSIVE RATS, Journal of hypertension, 16(3), 1998, pp. 349-355
COMPARISON OF EFFICACY AND SAFETY OF MIBEFRADIL, ENALAPRIL AND AMLODIPINE IN MILD-TO-MODERATE HYPERTENSION
Authors: KAHN JC JAILLON P GODIN M HERPIN D DARNE B MILORADOVICH T KOEN R
Citation: Jc. Kahn et al., COMPARISON OF EFFICACY AND SAFETY OF MIBEFRADIL, ENALAPRIL AND AMLODIPINE IN MILD-TO-MODERATE HYPERTENSION, Journal of hypertension, 16, 1998, pp. 31008-31008
INCREASED SURVIVAL AFTER LONG-TERM TREATMENT WITH MIBEFRADIL, A SELECTIVE T-CHANNEL CALCIUM-ANTAGONIST, IN HEART-FAILURE
Authors: MULDER P RICHARD V COMPAGNON P HENRY JP LALLEMAND F CLOZEL JP KOEN R MACE B THUILLEZ C
Citation: P. Mulder et al., INCREASED SURVIVAL AFTER LONG-TERM TREATMENT WITH MIBEFRADIL, A SELECTIVE T-CHANNEL CALCIUM-ANTAGONIST, IN HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 416-421
DRUG-INDUCED TORSADE-DE-POINTES - PRECLIN ICAL AND CLINICAL-STUDIES FOR THE PREDICTION OF A POTENTIAL PROARRHYTHMIC ADVERSE DRUG REACTION
Authors: JAILLON P DUPUIS B DAHAN R BOTTINEAU G CARON J CAZOR JL CHAUVENET M CLEMENT JP ESCANDE D FAISANDIER Y FUNCKBRENTANO C KOLSKY H KOEN R LACROIX D LEENHARDT A LEHNER JP PROST JF SWYNGHEDAUW B VASSORT G WEISSENBURGER J WOHLHUTER C
Citation: P. Jaillon et al., DRUG-INDUCED TORSADE-DE-POINTES - PRECLIN ICAL AND CLINICAL-STUDIES FOR THE PREDICTION OF A POTENTIAL PROARRHYTHMIC ADVERSE DRUG REACTION, Therapie, 52(4), 1997, pp. 271-280
EFFECTS OF THE CALCIUM-CHANNEL BLOCKER MIBEFRADIL ON SYSTEMIC HEMODYNAMICS, LEFT-VENTRICULAR REMODELING AND CARDIAC-FUNCTION IN A RAT MODELOF HEART-FAILURE
Authors: MULDER P DERUMEAUX GA RICHARD V KOEN R THUILLEZ C
Citation: P. Mulder et al., EFFECTS OF THE CALCIUM-CHANNEL BLOCKER MIBEFRADIL ON SYSTEMIC HEMODYNAMICS, LEFT-VENTRICULAR REMODELING AND CARDIAC-FUNCTION IN A RAT MODELOF HEART-FAILURE, Circulation, 96(8), 1997, pp. 3236-3236
EFFECTS OF THE CALCIUM-CHANNEL BLOCKER MIBEFRADIL ON SYSTEMIC HEMODYNAMICS AND LEFT-VENTRICULAR REMODELING IN RATS WITH HEART-FAILURE
Authors: MULDER P DERUMEAUX G RICHARD V KOEN R HENRY JP THUILLEZ C
Citation: P. Mulder et al., EFFECTS OF THE CALCIUM-CHANNEL BLOCKER MIBEFRADIL ON SYSTEMIC HEMODYNAMICS AND LEFT-VENTRICULAR REMODELING IN RATS WITH HEART-FAILURE, British Journal of Pharmacology, 122, 1997, pp. 239-239
THE ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET
Authors: LAURENT S VANHOUTTE P CAVERO I CHABRIER PE DUPUIS B ELGHOZI JL HAMON G JANIAK P JUILLET Y KHER A KOEN R MADONNA O MAFFRAND JP PRUNEAU D THUILLEZ C
Citation: S. Laurent et al., THE ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET, Fundamental and clinical pharmacology, 10(3), 1996, pp. 243-257
ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET
Authors: LAURENT S VANHOUTTE P CAVERO I CHABRIER PE DUPUIS B ELGHOZI JL HAMON G JANIAK P JUILLET Y KHER A KOEN R MADONNA O MAFFRAND JP PRUNEAU D THUILLEZ C MOURAD JJ
Citation: S. Laurent et al., ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET, Therapie, 50(4), 1995, pp. 387-398
Risultati: 1-8 |